跳至主要内容
临床试验/IRCT20231127060207N1
IRCT20231127060207N1招募中2 期

Efficacy and safety of tacrolimus in clinical pregnancy onset of repeated implantation failure (RIF) patients with elevated T-cell helper1/T-cell helper2 (Th1/Th2) ratio: a randomized controlled trial

Mazandaran University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 39 years(—)
性别
Female

入选标准

  • The patient should be = 39 years old.
  • The patient should have = 3 failures in the IVF.
  • Th1/Th2 cell ratio should be greater than or equal to 10.3.

排除标准

  • Patients with abnormal karyotypes, uterine abnormalities or defects, infections, endocrine diseases, and coagulation abnormalities or thrombosis.

研究者

相似试验

Tacrolimus in clinical pregnancy onset of repeated... | 临床试验